Moritaka Goto Selected Research

N(G),N(G')-dimethylarginine

6/2002	Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.
2/2002	Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moritaka Goto Research Topics

Disease

5	Insulin Resistance 03/2020 - 07/2013
3	Obesity 03/2020 - 12/2016
3	Body Weight (Weight, Body) 01/2020 - 07/2013
3	Hyperglycemia 12/2016 - 07/2002
2	Type 2 Diabetes Mellitus (MODY) 11/2016 - 07/2013
2	Glucose Intolerance 07/2013 - 05/2007
2	Ischemia 10/2003 - 06/2002
2	Hyperplasia 02/2003 - 02/2002
1	Inflammation (Inflammations) 01/2020
1	Carcinogenesis 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Neoplasms (Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Hypercholesterolemia 11/2018
1	Diabetes Mellitus 12/2016
1	Atherosclerosis 01/2016
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 07/2002

Drug/Important Bio-Agent (IBA)

6	anagliptinIBA 01/2020 - 07/2013
5	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 07/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2007
3	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 10/2003 - 02/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2003 - 02/2002
3	Arginine (L-Arginine)FDA Link 10/2003 - 02/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2003 - 02/2002
2	miglitol (Glyset)FDA Link 03/2020 - 12/2016
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 11/2016
2	CholesterolIBA 11/2018 - 01/2016
2	Insulin (Novolin)FDA Link 01/2017 - 11/2016
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2003 - 06/2002
2	AlloxanIBA 02/2003 - 07/2002
2	Carbachol (Carbastat)FDA Link 07/2002 - 06/2002
2	N(G),N(G')-dimethylarginineIBA 06/2002 - 02/2002
1	Glycoside Hydrolase InhibitorsIBA 03/2020
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Sodium-Glucose Transport ProteinsIBA 01/2017
1	Insulin Receptor Substrate ProteinsIBA 01/2017
1	GlucosidasesIBA 12/2016
1	Metformin (Glucophage)FDA LinkGeneric 12/2016
1	LeptinIBA 12/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2016
1	IncretinsIBA 11/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	GlucokinaseIBA 07/2013
1	symmetric dimethylarginineIBA 10/2003
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2003
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2003
1	polyolIBA 02/2003
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2003
1	fidarestatIBA 02/2003
1	Sorbitol (Yal)FDA Link 02/2003
1	Adenosine Triphosphate (ATP)IBA 07/2002
1	Serotonin (5 Hydroxytryptamine)IBA 07/2002
1	Cholinergic Agents (Cholinergics)IBA 07/2002
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2002
1	Endothelin-1 (Endothelin 1)IBA 02/2002
1	NucleotidesIBA 02/2002

Therapy/Procedure

1	Cell Transplantation 11/2019
1	Glycemic Control 12/2016
1	Therapeutics 12/2016
1	Intravenous Injections 07/2002